Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elanco Animal HealthELAN -8.60%69 FCF Margin % is 17.84% as of Jun. 2026, which is 297% above its 10-year median of 4.49. GuruFocus rates ELAN with a GF Score™ of 69/100 and a GF Value™ of $16.62 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 962 Drug Manufacturers companies, Elanco Animal Health ranks better than 64.55% on this metric.
The historical data trend for Elanco Animal Health's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elanco Animal Health FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elanco Animal Health (ELAN) has a FCF Margin % of 17.84% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Elanco Animal Health and its competitors. This is 297% above median its historical median of 4.49. According to the industry distribution chart, Elanco Animal Health ranks #341 out of 962 companies in the Drug Manufacturers industry, placing it in the top 35.4%.
Is Elanco Animal Health's FCF Margin % too high?
Elanco Animal Health's current FCF Margin % of 17.84% is 297% above median its 10-year median of 4.49. The Drug Manufacturers industry median FCF Margin % is 2.48. Elanco Animal Health's value of 17.84% is 619.4% above this industry median. Based on the distribution chart, Elanco Animal Health ranks #341 out of 962 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Elanco Animal Health has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's FCF Margin % compare to ALKS and LQDA?
According to the Drug Manufacturers industry distribution chart, Elanco Animal Health ranks #341 out of 962 companies for FCF Margin %. This puts Elanco Animal Health in the upper half of its industry. The industry median FCF Margin % is 2.48. Elanco Animal Health's value of 17.84% is 619.4% above this benchmark. While the company's 10-year median is 4.49 vs. the industry median of 2.48, Elanco Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elanco Animal Health's current FCF Margin % of 17.84% is 619.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Elanco Animal Health and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elanco Animal Health's current FCF Margin % is 17.84%, which is 297% above median its own 10-year median of 4.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Elanco Animal Health (ELAN) is currently considered Significantly Overvalued. The stock's GF Value™ is $16.62, compared to a current price of $22.12 — trading 33.1% above its estimated fair value. The current FCF Margin % is 17.84%, which is 297% above median its 10-year median of 4.49 and 619.4% above the Drug Manufacturers industry median of 2.48. Elanco Animal Health's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Elanco Animal Health (ELAN), the current FCF Margin % is 17.84% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elanco Animal Health (ELAN) Overvalued in 2026?
Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued.
The current stock price of $22.12 is trading 33.1% above its estimated GF Value™ of $16.62.
GuruFocus considers Elanco Animal Health to be Significantly Overvalued.
Key valuation signals for ELAN:
FCF Margin %: 17.84% (297% above median its 10-year median of 4.49)
GF Value™: $16.62 vs. price of $22.12 (33.1% above fair value)
Industry Position: 619.4% above the Drug Manufacturers median (#341 of 962)
No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
69GF Score
Get the complete analysis for ELAN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELAN has been successfully added to your 
